A Review of Accelerator-Produced Ga-68 with Solid Targets

Author(s): Kaelyn V. Becker, Margarita Chernysheva, Todd E. Barnhart, Katherine Gagnon, Jonathan W. Engle*

Journal Name: Current Radiopharmaceuticals

Volume 14 , Issue 4 , 2021

Become EABM
Become Reviewer
Call for Editor


Gallium-68 is a positron-emitting nuclide that has recently achieved clinical acceptance as the diagnostic radionuclide in PET tracers used for theranostic studies of lutetium-177 labeled therapeutic drugs due to the ease of access provided by germanium-68/gallium-68 generators. An alternative method of production currently being explored uses accelerators to form gallium-68 directly. This review of gallium-68 production strategies discusses available accelerator targetry at a range of beam energies and intensities, the many radiochemical separation techniques available to isolate Ga-68 from irradiated targets, isotopically enriched target material recovery, and the implications of these techniques for downstream radiolabeling applications.

Keywords: Radiochemical, PET, therapeutic molecule, gallium-68, radiochemistry, Lu-177 labeled.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 23 December, 2020
Page: [315 - 324]
Pages: 10
DOI: 10.2174/1874471013666201224113651
Price: $95

Article Metrics

PDF: 219